In the Annex to Framework Decision 2004/757/JHA, the following points 22, 23 and 24 are added:
‘22.
2-(Methylamino)-1-(2-methylphenyl)propan-1-one (2-methylmethcathinone, 2-MMC) ( *1 ) .
23.
2-(Ethylamino)-1-phenylpentan-1-one ( N -Ethylnorpentedrone, NEP) ( *1 ) .
24.
1-(4-Bromophenyl)-2-(methylamino)propan-1-one (4-bromomethcathinone, 4-BMC) ( *1 ) .
( *1 ) Commission Delegated Directive (EU) 2025/2062 of 14 October 2025 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of “drug” ( OJ L, 2025/2062, 23.12.2025, ELI: http://data.europa.eu/eli/dir_del/2025/2062/oj ).’."
( *1 ) Commission Delegated Directive (EU) 2025/2062 of 14 October 2025 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of “drug” ( OJ L, 2025/2062, 23.12.2025, ELI: http://data.europa.eu/eli/dir_del/2025/2062/oj ).’."
( *1 ) Commission Delegated Directive (EU) 2025/2062 of 14 October 2025 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of “drug” ( OJ L, 2025/2062, 23.12.2025, ELI: http://data.europa.eu/eli/dir_del/2025/2062/oj ).’."